240 related articles for article (PubMed ID: 12366387)
1. Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia.
Hennessy A; Orange S; Willis N; Painter DM; Child A; Horvath JS
Clin Exp Pharmacol Physiol; 2002 Nov; 29(11):968-71. PubMed ID: 12366387
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta expression in human placenta and placental bed during early pregnancy.
Simpson H; Robson SC; Bulmer JN; Barber A; Lyall F
Placenta; 2002 Jan; 23(1):44-58. PubMed ID: 11869091
[TBL] [Abstract][Full Text] [Related]
3. Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
Xu YT; Shen MH; Jin AY; Li H; Zhu R
Int J Gynaecol Obstet; 2017 Jun; 137(3):246-252. PubMed ID: 28281288
[TBL] [Abstract][Full Text] [Related]
4. [Expression of transforming growth factor-beta 1, vascular cell adhesion molecule-1 and endothelium-selectin in placenta of patients with pre-eclampsia].
Wang Y; Zhang X; Cheng GM; Ren CC
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):514-7. PubMed ID: 17083832
[TBL] [Abstract][Full Text] [Related]
5. Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia.
Benian A; Madazli R; Aksu F; Uzun H; Aydin S
Obstet Gynecol; 2002 Aug; 100(2):327-31. PubMed ID: 12151158
[TBL] [Abstract][Full Text] [Related]
6. Expression of TGF beta in the placental bed is not altered in sporadic miscarriage.
Ball E; Robson SC; Ayis S; Lyall F; Bulmer JN
Placenta; 2007; 28(8-9):965-71. PubMed ID: 17531316
[TBL] [Abstract][Full Text] [Related]
7. Placental tissue interleukin-10 receptor distribution in pre-eclampsia.
Hennessy A; Painter DM; Orange S; Horvath JS
Am J Reprod Immunol; 2003 Jun; 49(6):377-81. PubMed ID: 12951965
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia.
Huber A; Hefler L; Tempfer C; Zeisler H; Lebrecht A; Husslein P
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):168-71. PubMed ID: 11942909
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction.
Lyall F; Simpson H; Bulmer JN; Barber A; Robson SC
Am J Pathol; 2001 Nov; 159(5):1827-38. PubMed ID: 11696443
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
Naicker T; Khedun SM; Moodley J
J Obstet Gynaecol; 2002 May; 22(3):279-82. PubMed ID: 12521499
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
Ayatollahi M; Geramizadeh B; Samsami A
Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
[TBL] [Abstract][Full Text] [Related]
12. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation.
Lysiak JJ; Hunt J; Pringle GA; Lala PK
Placenta; 1995 Apr; 16(3):221-31. PubMed ID: 7638106
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
14. A deficiency of placental IL-10 in preeclampsia.
Hennessy A; Pilmore HL; Simmons LA; Painter DM
J Immunol; 1999 Sep; 163(6):3491-5. PubMed ID: 10477622
[TBL] [Abstract][Full Text] [Related]
15. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?
Clausen T; Djurovic S; Reseland JE; Berg K; Drevon CA; Henriksen T
Placenta; 2002 May; 23(5):380-5. PubMed ID: 12061853
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae.
Todros T; Marzioni D; Lorenzi T; Piccoli E; Capparuccia L; Perugini V; Cardaropoli S; Romagnoli R; Gesuita R; Rolfo A; Paulesu L; Castellucci M
Placenta; 2007; 28(11-12):1123-32. PubMed ID: 17664003
[TBL] [Abstract][Full Text] [Related]
17. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig.
Moussad EE; Rageh MA; Wilson AK; Geisert RD; Brigstock DR
Mol Pathol; 2002 Jun; 55(3):186-92. PubMed ID: 12032230
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta-1 (TGF-β1) gene single nucleotide polymorphisms (SNPs) and susceptibility to pre-eclampsia in Iranian women: A case-control study.
Khani M; Amani D; Taheripanah R; Sanadgol N; Feizollahzadeh S; Rahmani Z
Pregnancy Hypertens; 2015 Oct; 5(4):267-72. PubMed ID: 26597739
[TBL] [Abstract][Full Text] [Related]
19. Confocal laser scanning microscope study of cytokeratin immunofluorescence differences between villous and extravillous trophoblast: cytokeratin downregulation in pre-eclampsia.
Ockleford CD; Smith RK; Byrne S; Sanders R; Bosio P
Microsc Res Tech; 2004 May; 64(1):43-53. PubMed ID: 15287017
[TBL] [Abstract][Full Text] [Related]
20. Corin, an enzyme with a putative role in spiral artery remodeling, is up-regulated in late secretory endometrium and first trimester decidua.
Kaitu'u-Lino TJ; Ye L; Tuohey L; Dimitriadis E; Bulmer J; Rogers P; Menkhorst E; Van Sinderen M; Girling JE; Hannan N; Tong S
Hum Reprod; 2013 May; 28(5):1172-80. PubMed ID: 23434834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
